Gastroenterology
Volume 135, Issue 4 , Pages 1176-1184 , October 2008

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

  • Guruprasad P. Aithal

      Affiliations

    • University Hospitals NHS Trust, Nottingham, United Kingdom
    • Corresponding Author InformationAddress reprint requests to: Guruprasad P. Aithal, MD, PhD, Consultant Hepatobiliary Physician, D Floor, South Block, Queen's Medical Centre University Hospital, Derby Road, Nottingham NG72UH, United Kingdom. fax: +44 (0)115-9709012
    • ,
  • James A. Thomas

      Affiliations

    • University Hospitals NHS Trust, Nottingham, United Kingdom
    • ,
  • Philip V. Kaye

      Affiliations

    • University Hospitals NHS Trust, Nottingham, United Kingdom
    • ,
  • Adam Lawson

      Affiliations

    • University Hospitals NHS Trust, Nottingham, United Kingdom
    • ,
  • Stephen D. Ryder

      Affiliations

    • University Hospitals NHS Trust, Nottingham, United Kingdom
    • ,
  • Ian Spendlove

      Affiliations

    • University of Nottingham, Nottingham, United Kingdom
    • ,
  • Andrew S. Austin

      Affiliations

    • Derby City General Hospital, Derby, United Kingdom
    • ,
  • Jan G. Freeman

      Affiliations

    • Derby City General Hospital, Derby, United Kingdom
    • ,
  • Linda Morgan

      Affiliations

    • University of Nottingham, Nottingham, United Kingdom
    • ,
  • Jonathan Webber

      Affiliations

    • University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Received 12 May 2008 ,Accepted 19 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Takeda Pharmaceuticals UK provided the pioglitazone and placebo tablets for this investigator-initiated study. Jonathan Webber has received funding from Takeda, Novo, Sanofi-Aventis, and Pfizer to attend meetings. Investigator conflicts of interests were disclosed to study participants.

PII: S0016-5085(08)01101-3

doi: 10.1053/j.gastro.2008.06.047

Gastroenterology
Volume 135, Issue 4 , Pages 1176-1184 , October 2008

Article Tools

* Image Usage & Resolution